Pharming Group NV - Company & Market Research Reports

The Pharming Group offers novel platforms for the production of protein therapeutics, as well as processes for the purification and formulation. The company’s best known product is Ruconest, a human C1 inhibitor. Human C1 inhibitor is a protein involved in the regulation of the complement and contact pathways of the immune system. Pharming Group N.V. is headquartered in Leiden, the Netherlands.

From
From
From
From
From
From
Hemophilia A - Pipeline Review, H2 2018 - Product Thumbnail Image

Hemophilia A - Pipeline Review, H2 2018

  • Drug Pipelines
  • 186 Pages
From
Hemophilia B - Pipeline Review, H2 2018 - Product Thumbnail Image

Hemophilia B - Pipeline Review, H2 2018

  • Drug Pipelines
  • 135 Pages
From
Hemophilia A - Pipeline Review, H1 2018 - Product Thumbnail Image

Hemophilia A - Pipeline Review, H1 2018

  • Drug Pipelines
  • 182 Pages
From
Hemophilia B - Pipeline Review, H1 2018 - Product Thumbnail Image

Hemophilia B - Pipeline Review, H1 2018

  • Drug Pipelines
  • 126 Pages
From
From
Pancreatitis - Pipeline Review, H2 2018 - Product Thumbnail Image

Pancreatitis - Pipeline Review, H2 2018

  • Drug Pipelines
  • 87 Pages
From
From
Pancreatitis - Pipeline Review, H1 2018 - Product Thumbnail Image

Pancreatitis - Pipeline Review, H1 2018

  • Drug Pipelines
  • 79 Pages
From
Loading Indicator
adroll